Don't miss out on the latest news, evidence and CPD opportunities on medicines and medical tests - sign up today.
You have not selected any filters.
Consider recommendations for assessment of anxiety disorders and evidence-based approaches to management. Both psychological and pharmacological treatment options will be discussed.
Confidently recognise when low back pain requires further investigation and identify patients at risk of chronic, disabling pain.
Review your PPI prescribing for patients with GORD and be guided on implementing an effective step-down approach for your patients.
How would you advise a patient with well-controlled gastro-oesophageal reflux disease (GORD) who would like to continue their proton pump inhibitor (PPI) therapy?
Kyle, a 47-year-old man, presents with a history of low back pain for 8 days. He wants to know if he has damaged his back and is requesting imaging. What now?
Use a stepwise approach to manage patients with COPD and individualise choice of inhaler based on patient-specific factors. This Clinical e-Audit requires data to be submitted for only SEVEN (7) patients.This activity is funded by Novartis Pharmaceuticals Australia Pty Ltd and managed through VentureWise, a wholly owned subsidiary of NPS MedicineWise. The content has been developed by NPS MedicineWise with complete independence and editorial control and is based on best practice guidelines.